These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27284986)

  • 1. Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia.
    Mazzuti L; Lozzi MA; Riva E; Maida P; Falasca F; Antonelli G; Turriziani O
    New Microbiol; 2016 Jul; 39(3):224-227. PubMed ID: 27284986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
    Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
    J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system.
    Sizmann D; Boeck C; Boelter J; Fischer D; Miethke M; Nicolaus S; Zadak M; Babiel R
    J Clin Virol; 2007 Apr; 38(4):326-33. PubMed ID: 17344093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.
    Pas S; Molenkamp R; Schinkel J; Rebers S; Copra C; Seven-Deniz S; Thamke D; de Knegt RJ; Haagmans BL; Schutten M
    J Clin Microbiol; 2013 Jan; 51(1):238-42. PubMed ID: 23152551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA.
    Sarrazin C; Dragan A; Gärtner BC; Forman MS; Traver S; Zeuzem S; Valsamakis A
    J Clin Virol; 2008 Oct; 43(2):162-8. PubMed ID: 18692434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV RNA detection in HCV antibody-positive patients with the COBAS AmpliPrep/COBAS TaqMan HCV test, v2.0 in comparison with FDA-approved nucleic acid tests.
    Butcher A; Aslam S; Hemyari P; Cowen U; Heilek G
    J Clin Virol; 2014 Aug; 60(4):336-40. PubMed ID: 24881014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity.
    Vermehren J; Colucci G; Gohl P; Hamdi N; Abdelaziz AI; Karey U; Thamke D; Zitzer H; Zeuzem S; Sarrazin C
    J Clin Microbiol; 2011 Sep; 49(9):3309-15. PubMed ID: 21752967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of COBAS AmpliPrep/COBAS TaqMan 48 and VERSANT HCV-RNA 3.0 systems for the determination of hepatitis C virus load].
    Kaklikkaya N; Buruk CK; Tosun I; Bayramoğlu G; Ertürk M
    Mikrobiyol Bul; 2009 Oct; 43(4):657-60. PubMed ID: 20084920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.
    Vermehren J; Bourlière M; Pol S; Marcellin P; Hyland RH; Jiang D; Brainard DM; Zeuzem S; Welzel TM
    J Clin Virol; 2017 Apr; 89():51-56. PubMed ID: 28259054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative evaluation between real time Roche COBas TAQMAN 48 HCV and bDNA Bayer Versant HCV 3.0.
    Giraldi C; Noto A; Tenuta R; Greco F; Perugini D; Spadafora M; Bianco AM; Savino O; Natale A
    New Microbiol; 2006 Oct; 29(4):243-50. PubMed ID: 17201090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA pure LC instrument.
    Germer JJ; Harmsen WS; Mandrekar JN; Mitchell PS; Yao JD
    J Clin Microbiol; 2005 Jan; 43(1):293-8. PubMed ID: 15634985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test.
    Pyne MT; Hillyard DR
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):25-30. PubMed ID: 23806661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
    Gelderblom HC; Menting S; Beld MG
    Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV RNA measurement in samples with diverse genotypes using versions 1 and 2 of the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV test.
    Pyne MT; Mallory M; Hillyard DR
    J Clin Virol; 2015 Apr; 65():54-7. PubMed ID: 25766989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA.
    Wolff D; Gerritzen A
    Clin Chem Lab Med; 2007; 45(7):917-22. PubMed ID: 17617038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype impact on HCV RNA levels determined with the VERSANT HCV RNA 1.0 assay (kPCR).
    Kessler HH; Hübner M; Konrad PM; Stelzl E; Stübler MM; Baser MH; Santner BI
    J Clin Virol; 2013 Nov; 58(3):522-7. PubMed ID: 24095028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.
    Pierce VM; Eversley JS; Tran TK; Rosenberg ES
    Clin Chem Lab Med; 2017 Jun; 55(7):956-961. PubMed ID: 27988503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
    Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
    J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
    Taylor N; Haschke-Becher E; Greil R; Strasser M; Oberkofler H
    Antivir Ther; 2014; 19(5):449-54. PubMed ID: 24430620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.
    Worlock A; Blair D; Hunsicker M; Le-Nguyen T; Motta C; Nguyen C; Papachristou E; Pham J; Williams A; Vi M; Vinluan B; Hatzakis A
    Virol J; 2017 Apr; 14(1):66. PubMed ID: 28372576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.